nodes	percent_of_prediction	percent_of_DWPC	metapath
Rizatriptan—MAOA—Zonisamide—epilepsy syndrome	0.166	0.455	CbGbCtD
Rizatriptan—CYP1A2—Carbamazepine—epilepsy syndrome	0.0404	0.111	CbGbCtD
Rizatriptan—CYP1A2—Primidone—epilepsy syndrome	0.0377	0.103	CbGbCtD
Rizatriptan—CYP1A2—Propofol—epilepsy syndrome	0.0338	0.0926	CbGbCtD
Rizatriptan—CYP1A2—Phenobarbital—epilepsy syndrome	0.0323	0.0885	CbGbCtD
Rizatriptan—CYP1A2—Diazepam—epilepsy syndrome	0.0306	0.0839	CbGbCtD
Rizatriptan—CYP1A2—Valproic Acid—epilepsy syndrome	0.0241	0.0662	CbGbCtD
Rizatriptan—HTR1D—meninx—epilepsy syndrome	0.021	0.196	CbGeAlD
Rizatriptan—MAOA—locus ceruleus—epilepsy syndrome	0.00774	0.0723	CbGeAlD
Rizatriptan—HTR1F—ganglion—epilepsy syndrome	0.00756	0.0707	CbGeAlD
Rizatriptan—HTR1B—telencephalic ventricle—epilepsy syndrome	0.00498	0.0465	CbGeAlD
Rizatriptan—HTR1D—telencephalic ventricle—epilepsy syndrome	0.00482	0.045	CbGeAlD
Rizatriptan—HTR1A—telencephalic ventricle—epilepsy syndrome	0.00402	0.0375	CbGeAlD
Rizatriptan—HTR1F—forebrain—epilepsy syndrome	0.00317	0.0297	CbGeAlD
Rizatriptan—HTR1B—ganglion—epilepsy syndrome	0.0031	0.029	CbGeAlD
Rizatriptan—HTR1D—ganglion—epilepsy syndrome	0.003	0.028	CbGeAlD
Rizatriptan—HTR1F—telencephalon—epilepsy syndrome	0.00292	0.0273	CbGeAlD
Rizatriptan—HTR1A—ganglion—epilepsy syndrome	0.0025	0.0234	CbGeAlD
Rizatriptan—MAOA—ganglion—epilepsy syndrome	0.00228	0.0214	CbGeAlD
Rizatriptan—HTR1A—hindbrain—epilepsy syndrome	0.0019	0.0177	CbGeAlD
Rizatriptan—HTR1F—head—epilepsy syndrome	0.00182	0.017	CbGeAlD
Rizatriptan—Sumatriptan—SLCO1A2—epilepsy syndrome	0.00175	0.411	CrCbGaD
Rizatriptan—MAOA—hindbrain—epilepsy syndrome	0.00173	0.0162	CbGeAlD
Rizatriptan—HTR1F—nervous system—epilepsy syndrome	0.00172	0.0161	CbGeAlD
Rizatriptan—HTR1F—central nervous system—epilepsy syndrome	0.00166	0.0155	CbGeAlD
Rizatriptan—HTR1B—brainstem—epilepsy syndrome	0.00135	0.0126	CbGeAlD
Rizatriptan—HTR1F—brain—epilepsy syndrome	0.00132	0.0123	CbGeAlD
Rizatriptan—HTR1D—brainstem—epilepsy syndrome	0.0013	0.0122	CbGeAlD
Rizatriptan—HTR1B—forebrain—epilepsy syndrome	0.0013	0.0122	CbGeAlD
Rizatriptan—HTR1D—forebrain—epilepsy syndrome	0.00126	0.0118	CbGeAlD
Rizatriptan—HTR1B—telencephalon—epilepsy syndrome	0.0012	0.0112	CbGeAlD
Rizatriptan—HTR1D—telencephalon—epilepsy syndrome	0.00116	0.0108	CbGeAlD
Rizatriptan—HTR1A—brainstem—epilepsy syndrome	0.00109	0.0102	CbGeAlD
Rizatriptan—HTR1A—forebrain—epilepsy syndrome	0.00105	0.0098	CbGeAlD
Rizatriptan—MAOA—brainstem—epilepsy syndrome	0.000993	0.00928	CbGeAlD
Rizatriptan—HTR1A—telencephalon—epilepsy syndrome	0.000964	0.00902	CbGeAlD
Rizatriptan—MAOA—forebrain—epilepsy syndrome	0.000958	0.00896	CbGeAlD
Rizatriptan—MAOA—telencephalon—epilepsy syndrome	0.000881	0.00824	CbGeAlD
Rizatriptan—HTR1B—midbrain—epilepsy syndrome	0.000858	0.00802	CbGeAlD
Rizatriptan—HTR1B—spinal cord—epilepsy syndrome	0.000837	0.00783	CbGeAlD
Rizatriptan—HTR1D—midbrain—epilepsy syndrome	0.000831	0.00777	CbGeAlD
Rizatriptan—HTR1B—head—epilepsy syndrome	0.000744	0.00696	CbGeAlD
Rizatriptan—Sumatriptan—ABCG2—epilepsy syndrome	0.000739	0.174	CrCbGaD
Rizatriptan—HTR1D—head—epilepsy syndrome	0.00072	0.00674	CbGeAlD
Rizatriptan—HTR1B—nervous system—epilepsy syndrome	0.000706	0.0066	CbGeAlD
Rizatriptan—HTR1A—midbrain—epilepsy syndrome	0.000693	0.00647	CbGeAlD
Rizatriptan—MAOA—medulla oblongata—epilepsy syndrome	0.000692	0.00647	CbGeAlD
Rizatriptan—HTR1D—nervous system—epilepsy syndrome	0.000683	0.00639	CbGeAlD
Rizatriptan—HTR1B—central nervous system—epilepsy syndrome	0.000679	0.00635	CbGeAlD
Rizatriptan—HTR1A—spinal cord—epilepsy syndrome	0.000676	0.00632	CbGeAlD
Rizatriptan—HTR1D—central nervous system—epilepsy syndrome	0.000658	0.00615	CbGeAlD
Rizatriptan—MAOA—midbrain—epilepsy syndrome	0.000633	0.00592	CbGeAlD
Rizatriptan—MAOA—spinal cord—epilepsy syndrome	0.000617	0.00577	CbGeAlD
Rizatriptan—Almotriptan—CYP2C19—epilepsy syndrome	0.000603	0.142	CrCbGaD
Rizatriptan—HTR1A—head—epilepsy syndrome	0.000601	0.00561	CbGeAlD
Rizatriptan—HTR1A—nervous system—epilepsy syndrome	0.000569	0.00532	CbGeAlD
Rizatriptan—MAOA—head—epilepsy syndrome	0.000549	0.00513	CbGeAlD
Rizatriptan—HTR1A—central nervous system—epilepsy syndrome	0.000548	0.00512	CbGeAlD
Rizatriptan—HTR1B—brain—epilepsy syndrome	0.000539	0.00504	CbGeAlD
Rizatriptan—HTR1A—cerebellum—epilepsy syndrome	0.000536	0.00501	CbGeAlD
Rizatriptan—HTR1D—brain—epilepsy syndrome	0.000522	0.00488	CbGeAlD
Rizatriptan—MAOA—nervous system—epilepsy syndrome	0.00052	0.00486	CbGeAlD
Rizatriptan—MAOA—central nervous system—epilepsy syndrome	0.000501	0.00468	CbGeAlD
Rizatriptan—MAOA—cerebellum—epilepsy syndrome	0.000489	0.00458	CbGeAlD
Rizatriptan—Almotriptan—CYP2D6—epilepsy syndrome	0.000447	0.105	CrCbGaD
Rizatriptan—HTR1A—brain—epilepsy syndrome	0.000435	0.00407	CbGeAlD
Rizatriptan—Melatonin—CYP2C19—epilepsy syndrome	0.000408	0.0959	CrCbGaD
Rizatriptan—MAOA—brain—epilepsy syndrome	0.000398	0.00372	CbGeAlD
Rizatriptan—Sumatriptan—ABCB1—epilepsy syndrome	0.000308	0.0723	CrCbGaD
Rizatriptan—Asthenia—Oxcarbazepine—epilepsy syndrome	8.58e-05	0.000244	CcSEcCtD
Rizatriptan—Pruritus—Clonazepam—epilepsy syndrome	8.56e-05	0.000243	CcSEcCtD
Rizatriptan—Vomiting—Vigabatrin—epilepsy syndrome	8.56e-05	0.000243	CcSEcCtD
Rizatriptan—Hyperhidrosis—Valproic Acid—epilepsy syndrome	8.52e-05	0.000242	CcSEcCtD
Rizatriptan—Cough—Pregabalin—epilepsy syndrome	8.52e-05	0.000242	CcSEcCtD
Rizatriptan—Pruritus—Phenytoin—epilepsy syndrome	8.5e-05	0.000242	CcSEcCtD
Rizatriptan—Nausea—Levetiracetam—epilepsy syndrome	8.5e-05	0.000241	CcSEcCtD
Rizatriptan—Rash—Vigabatrin—epilepsy syndrome	8.49e-05	0.000241	CcSEcCtD
Rizatriptan—Dizziness—Felbamate—epilepsy syndrome	8.48e-05	0.000241	CcSEcCtD
Rizatriptan—Dermatitis—Vigabatrin—epilepsy syndrome	8.48e-05	0.000241	CcSEcCtD
Rizatriptan—Pruritus—Oxcarbazepine—epilepsy syndrome	8.46e-05	0.00024	CcSEcCtD
Rizatriptan—Convulsion—Pregabalin—epilepsy syndrome	8.46e-05	0.00024	CcSEcCtD
Rizatriptan—Hypersensitivity—Carbamazepine—epilepsy syndrome	8.45e-05	0.00024	CcSEcCtD
Rizatriptan—Vision blurred—Gabapentin—epilepsy syndrome	8.44e-05	0.00024	CcSEcCtD
Rizatriptan—Headache—Vigabatrin—epilepsy syndrome	8.43e-05	0.00024	CcSEcCtD
Rizatriptan—Hypertension—Pregabalin—epilepsy syndrome	8.43e-05	0.000239	CcSEcCtD
Rizatriptan—Vomiting—Diazepam—epilepsy syndrome	8.43e-05	0.000239	CcSEcCtD
Rizatriptan—Anorexia—Valproic Acid—epilepsy syndrome	8.4e-05	0.000239	CcSEcCtD
Rizatriptan—Tremor—Gabapentin—epilepsy syndrome	8.39e-05	0.000238	CcSEcCtD
Rizatriptan—Rash—Diazepam—epilepsy syndrome	8.36e-05	0.000237	CcSEcCtD
Rizatriptan—Dermatitis—Diazepam—epilepsy syndrome	8.35e-05	0.000237	CcSEcCtD
Rizatriptan—Arthralgia—Pregabalin—epilepsy syndrome	8.31e-05	0.000236	CcSEcCtD
Rizatriptan—Chest pain—Pregabalin—epilepsy syndrome	8.31e-05	0.000236	CcSEcCtD
Rizatriptan—Myalgia—Pregabalin—epilepsy syndrome	8.31e-05	0.000236	CcSEcCtD
Rizatriptan—Dizziness—Zonisamide—epilepsy syndrome	8.3e-05	0.000236	CcSEcCtD
Rizatriptan—Headache—Diazepam—epilepsy syndrome	8.3e-05	0.000236	CcSEcCtD
Rizatriptan—Anxiety—Pregabalin—epilepsy syndrome	8.28e-05	0.000235	CcSEcCtD
Rizatriptan—Diarrhoea—Clonazepam—epilepsy syndrome	8.28e-05	0.000235	CcSEcCtD
Rizatriptan—Asthenia—Carbamazepine—epilepsy syndrome	8.23e-05	0.000234	CcSEcCtD
Rizatriptan—Agitation—Gabapentin—epilepsy syndrome	8.23e-05	0.000234	CcSEcCtD
Rizatriptan—Diarrhoea—Phenytoin—epilepsy syndrome	8.22e-05	0.000234	CcSEcCtD
Rizatriptan—Discomfort—Pregabalin—epilepsy syndrome	8.21e-05	0.000233	CcSEcCtD
Rizatriptan—Nausea—Fosphenytoin—epilepsy syndrome	8.2e-05	0.000233	CcSEcCtD
Rizatriptan—Diarrhoea—Oxcarbazepine—epilepsy syndrome	8.18e-05	0.000232	CcSEcCtD
Rizatriptan—Angioedema—Gabapentin—epilepsy syndrome	8.18e-05	0.000232	CcSEcCtD
Rizatriptan—Hypersensitivity—Lamotrigine—epilepsy syndrome	8.17e-05	0.000232	CcSEcCtD
Rizatriptan—Vomiting—Felbamate—epilepsy syndrome	8.16e-05	0.000232	CcSEcCtD
Rizatriptan—Dry mouth—Pregabalin—epilepsy syndrome	8.13e-05	0.000231	CcSEcCtD
Rizatriptan—Pruritus—Carbamazepine—epilepsy syndrome	8.12e-05	0.000231	CcSEcCtD
Rizatriptan—Rash—Felbamate—epilepsy syndrome	8.09e-05	0.00023	CcSEcCtD
Rizatriptan—Dermatitis—Felbamate—epilepsy syndrome	8.08e-05	0.00023	CcSEcCtD
Rizatriptan—Tinnitus—Topiramate—epilepsy syndrome	8.07e-05	0.000229	CcSEcCtD
Rizatriptan—Vertigo—Gabapentin—epilepsy syndrome	8.04e-05	0.000228	CcSEcCtD
Rizatriptan—Headache—Felbamate—epilepsy syndrome	8.04e-05	0.000228	CcSEcCtD
Rizatriptan—Confusional state—Pregabalin—epilepsy syndrome	8.03e-05	0.000228	CcSEcCtD
Rizatriptan—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	8.03e-05	0.000228	CcSEcCtD
Rizatriptan—Flushing—Topiramate—epilepsy syndrome	8.03e-05	0.000228	CcSEcCtD
Rizatriptan—Syncope—Gabapentin—epilepsy syndrome	8.03e-05	0.000228	CcSEcCtD
Rizatriptan—Dizziness—Clonazepam—epilepsy syndrome	8e-05	0.000227	CcSEcCtD
Rizatriptan—Nausea—Vigabatrin—epilepsy syndrome	8e-05	0.000227	CcSEcCtD
Rizatriptan—Vomiting—Zonisamide—epilepsy syndrome	7.98e-05	0.000227	CcSEcCtD
Rizatriptan—Insomnia—Valproic Acid—epilepsy syndrome	7.97e-05	0.000226	CcSEcCtD
Rizatriptan—Anaphylactic shock—Pregabalin—epilepsy syndrome	7.97e-05	0.000226	CcSEcCtD
Rizatriptan—Oedema—Pregabalin—epilepsy syndrome	7.97e-05	0.000226	CcSEcCtD
Rizatriptan—Asthenia—Lamotrigine—epilepsy syndrome	7.96e-05	0.000226	CcSEcCtD
Rizatriptan—Dizziness—Phenytoin—epilepsy syndrome	7.95e-05	0.000226	CcSEcCtD
Rizatriptan—Rash—Zonisamide—epilepsy syndrome	7.92e-05	0.000225	CcSEcCtD
Rizatriptan—Paraesthesia—Valproic Acid—epilepsy syndrome	7.91e-05	0.000225	CcSEcCtD
Rizatriptan—Palpitations—Gabapentin—epilepsy syndrome	7.91e-05	0.000225	CcSEcCtD
Rizatriptan—Dermatitis—Zonisamide—epilepsy syndrome	7.91e-05	0.000225	CcSEcCtD
Rizatriptan—Dizziness—Oxcarbazepine—epilepsy syndrome	7.91e-05	0.000225	CcSEcCtD
Rizatriptan—Nausea—Diazepam—epilepsy syndrome	7.87e-05	0.000224	CcSEcCtD
Rizatriptan—Loss of consciousness—Gabapentin—epilepsy syndrome	7.87e-05	0.000223	CcSEcCtD
Rizatriptan—Headache—Zonisamide—epilepsy syndrome	7.87e-05	0.000223	CcSEcCtD
Rizatriptan—Dyspnoea—Valproic Acid—epilepsy syndrome	7.86e-05	0.000223	CcSEcCtD
Rizatriptan—Diarrhoea—Carbamazepine—epilepsy syndrome	7.85e-05	0.000223	CcSEcCtD
Rizatriptan—Angiopathy—Topiramate—epilepsy syndrome	7.85e-05	0.000223	CcSEcCtD
Rizatriptan—Pruritus—Lamotrigine—epilepsy syndrome	7.85e-05	0.000223	CcSEcCtD
Rizatriptan—Shock—Pregabalin—epilepsy syndrome	7.84e-05	0.000223	CcSEcCtD
Rizatriptan—Somnolence—Valproic Acid—epilepsy syndrome	7.83e-05	0.000223	CcSEcCtD
Rizatriptan—Nervous system disorder—Pregabalin—epilepsy syndrome	7.81e-05	0.000222	CcSEcCtD
Rizatriptan—Cough—Gabapentin—epilepsy syndrome	7.81e-05	0.000222	CcSEcCtD
Rizatriptan—Tachycardia—Pregabalin—epilepsy syndrome	7.78e-05	0.000221	CcSEcCtD
Rizatriptan—Chills—Topiramate—epilepsy syndrome	7.76e-05	0.00022	CcSEcCtD
Rizatriptan—Dyspepsia—Valproic Acid—epilepsy syndrome	7.76e-05	0.00022	CcSEcCtD
Rizatriptan—Convulsion—Gabapentin—epilepsy syndrome	7.76e-05	0.00022	CcSEcCtD
Rizatriptan—Hypertension—Gabapentin—epilepsy syndrome	7.73e-05	0.000219	CcSEcCtD
Rizatriptan—Hyperhidrosis—Pregabalin—epilepsy syndrome	7.7e-05	0.000219	CcSEcCtD
Rizatriptan—Vomiting—Clonazepam—epilepsy syndrome	7.69e-05	0.000219	CcSEcCtD
Rizatriptan—Decreased appetite—Valproic Acid—epilepsy syndrome	7.66e-05	0.000218	CcSEcCtD
Rizatriptan—Vomiting—Phenytoin—epilepsy syndrome	7.64e-05	0.000217	CcSEcCtD
Rizatriptan—Rash—Clonazepam—epilepsy syndrome	7.63e-05	0.000217	CcSEcCtD
Rizatriptan—Dermatitis—Clonazepam—epilepsy syndrome	7.62e-05	0.000217	CcSEcCtD
Rizatriptan—Myalgia—Gabapentin—epilepsy syndrome	7.62e-05	0.000216	CcSEcCtD
Rizatriptan—Arthralgia—Gabapentin—epilepsy syndrome	7.62e-05	0.000216	CcSEcCtD
Rizatriptan—Chest pain—Gabapentin—epilepsy syndrome	7.62e-05	0.000216	CcSEcCtD
Rizatriptan—Nausea—Felbamate—epilepsy syndrome	7.62e-05	0.000216	CcSEcCtD
Rizatriptan—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	7.61e-05	0.000216	CcSEcCtD
Rizatriptan—Vomiting—Oxcarbazepine—epilepsy syndrome	7.6e-05	0.000216	CcSEcCtD
Rizatriptan—Fatigue—Valproic Acid—epilepsy syndrome	7.6e-05	0.000216	CcSEcCtD
Rizatriptan—Anxiety—Gabapentin—epilepsy syndrome	7.59e-05	0.000216	CcSEcCtD
Rizatriptan—Anorexia—Pregabalin—epilepsy syndrome	7.59e-05	0.000216	CcSEcCtD
Rizatriptan—Dizziness—Carbamazepine—epilepsy syndrome	7.59e-05	0.000216	CcSEcCtD
Rizatriptan—Diarrhoea—Lamotrigine—epilepsy syndrome	7.59e-05	0.000216	CcSEcCtD
Rizatriptan—Headache—Clonazepam—epilepsy syndrome	7.58e-05	0.000215	CcSEcCtD
Rizatriptan—Rash—Phenytoin—epilepsy syndrome	7.58e-05	0.000215	CcSEcCtD
Rizatriptan—Mental disorder—Topiramate—epilepsy syndrome	7.58e-05	0.000215	CcSEcCtD
Rizatriptan—Dermatitis—Phenytoin—epilepsy syndrome	7.57e-05	0.000215	CcSEcCtD
Rizatriptan—Rash—Oxcarbazepine—epilepsy syndrome	7.54e-05	0.000214	CcSEcCtD
Rizatriptan—Constipation—Valproic Acid—epilepsy syndrome	7.54e-05	0.000214	CcSEcCtD
Rizatriptan—Pain—Valproic Acid—epilepsy syndrome	7.54e-05	0.000214	CcSEcCtD
Rizatriptan—Dermatitis—Oxcarbazepine—epilepsy syndrome	7.53e-05	0.000214	CcSEcCtD
Rizatriptan—Headache—Phenytoin—epilepsy syndrome	7.53e-05	0.000214	CcSEcCtD
Rizatriptan—Erythema—Topiramate—epilepsy syndrome	7.53e-05	0.000214	CcSEcCtD
Rizatriptan—Discomfort—Gabapentin—epilepsy syndrome	7.53e-05	0.000214	CcSEcCtD
Rizatriptan—Headache—Oxcarbazepine—epilepsy syndrome	7.49e-05	0.000213	CcSEcCtD
Rizatriptan—Nausea—Zonisamide—epilepsy syndrome	7.46e-05	0.000212	CcSEcCtD
Rizatriptan—Dry mouth—Gabapentin—epilepsy syndrome	7.45e-05	0.000212	CcSEcCtD
Rizatriptan—Flatulence—Topiramate—epilepsy syndrome	7.42e-05	0.000211	CcSEcCtD
Rizatriptan—Tension—Topiramate—epilepsy syndrome	7.39e-05	0.00021	CcSEcCtD
Rizatriptan—Dysgeusia—Topiramate—epilepsy syndrome	7.37e-05	0.000209	CcSEcCtD
Rizatriptan—Confusional state—Gabapentin—epilepsy syndrome	7.37e-05	0.000209	CcSEcCtD
Rizatriptan—Dizziness—Lamotrigine—epilepsy syndrome	7.33e-05	0.000208	CcSEcCtD
Rizatriptan—Nervousness—Topiramate—epilepsy syndrome	7.31e-05	0.000208	CcSEcCtD
Rizatriptan—Oedema—Gabapentin—epilepsy syndrome	7.31e-05	0.000207	CcSEcCtD
Rizatriptan—Anaphylactic shock—Gabapentin—epilepsy syndrome	7.31e-05	0.000207	CcSEcCtD
Rizatriptan—Vomiting—Carbamazepine—epilepsy syndrome	7.3e-05	0.000207	CcSEcCtD
Rizatriptan—Feeling abnormal—Valproic Acid—epilepsy syndrome	7.26e-05	0.000206	CcSEcCtD
Rizatriptan—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	7.26e-05	0.000206	CcSEcCtD
Rizatriptan—Muscle spasms—Topiramate—epilepsy syndrome	7.24e-05	0.000206	CcSEcCtD
Rizatriptan—Rash—Carbamazepine—epilepsy syndrome	7.23e-05	0.000205	CcSEcCtD
Rizatriptan—Dermatitis—Carbamazepine—epilepsy syndrome	7.23e-05	0.000205	CcSEcCtD
Rizatriptan—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	7.21e-05	0.000205	CcSEcCtD
Rizatriptan—Insomnia—Pregabalin—epilepsy syndrome	7.21e-05	0.000205	CcSEcCtD
Rizatriptan—Nausea—Clonazepam—epilepsy syndrome	7.19e-05	0.000204	CcSEcCtD
Rizatriptan—Headache—Carbamazepine—epilepsy syndrome	7.19e-05	0.000204	CcSEcCtD
Rizatriptan—Shock—Gabapentin—epilepsy syndrome	7.19e-05	0.000204	CcSEcCtD
Rizatriptan—Nervous system disorder—Gabapentin—epilepsy syndrome	7.16e-05	0.000203	CcSEcCtD
Rizatriptan—Paraesthesia—Pregabalin—epilepsy syndrome	7.15e-05	0.000203	CcSEcCtD
Rizatriptan—Nausea—Phenytoin—epilepsy syndrome	7.14e-05	0.000203	CcSEcCtD
Rizatriptan—Tachycardia—Gabapentin—epilepsy syndrome	7.13e-05	0.000202	CcSEcCtD
Rizatriptan—Dyspnoea—Pregabalin—epilepsy syndrome	7.1e-05	0.000202	CcSEcCtD
Rizatriptan—Nausea—Oxcarbazepine—epilepsy syndrome	7.1e-05	0.000202	CcSEcCtD
Rizatriptan—Vision blurred—Topiramate—epilepsy syndrome	7.1e-05	0.000202	CcSEcCtD
Rizatriptan—Somnolence—Pregabalin—epilepsy syndrome	7.08e-05	0.000201	CcSEcCtD
Rizatriptan—Hyperhidrosis—Gabapentin—epilepsy syndrome	7.06e-05	0.000201	CcSEcCtD
Rizatriptan—Tremor—Topiramate—epilepsy syndrome	7.06e-05	0.0002	CcSEcCtD
Rizatriptan—Vomiting—Lamotrigine—epilepsy syndrome	7.05e-05	0.0002	CcSEcCtD
Rizatriptan—Urticaria—Valproic Acid—epilepsy syndrome	7e-05	0.000199	CcSEcCtD
Rizatriptan—Rash—Lamotrigine—epilepsy syndrome	6.99e-05	0.000199	CcSEcCtD
Rizatriptan—Dermatitis—Lamotrigine—epilepsy syndrome	6.99e-05	0.000198	CcSEcCtD
Rizatriptan—Abdominal pain—Valproic Acid—epilepsy syndrome	6.97e-05	0.000198	CcSEcCtD
Rizatriptan—Body temperature increased—Valproic Acid—epilepsy syndrome	6.97e-05	0.000198	CcSEcCtD
Rizatriptan—Anorexia—Gabapentin—epilepsy syndrome	6.96e-05	0.000198	CcSEcCtD
Rizatriptan—Headache—Lamotrigine—epilepsy syndrome	6.95e-05	0.000197	CcSEcCtD
Rizatriptan—Decreased appetite—Pregabalin—epilepsy syndrome	6.93e-05	0.000197	CcSEcCtD
Rizatriptan—Agitation—Topiramate—epilepsy syndrome	6.92e-05	0.000197	CcSEcCtD
Rizatriptan—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	6.88e-05	0.000195	CcSEcCtD
Rizatriptan—Fatigue—Pregabalin—epilepsy syndrome	6.87e-05	0.000195	CcSEcCtD
Rizatriptan—Nausea—Carbamazepine—epilepsy syndrome	6.82e-05	0.000194	CcSEcCtD
Rizatriptan—Constipation—Pregabalin—epilepsy syndrome	6.81e-05	0.000193	CcSEcCtD
Rizatriptan—Pain—Pregabalin—epilepsy syndrome	6.81e-05	0.000193	CcSEcCtD
Rizatriptan—Vertigo—Topiramate—epilepsy syndrome	6.77e-05	0.000192	CcSEcCtD
Rizatriptan—Syncope—Topiramate—epilepsy syndrome	6.75e-05	0.000192	CcSEcCtD
Rizatriptan—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	6.66e-05	0.000189	CcSEcCtD
Rizatriptan—Palpitations—Topiramate—epilepsy syndrome	6.65e-05	0.000189	CcSEcCtD
Rizatriptan—Loss of consciousness—Topiramate—epilepsy syndrome	6.62e-05	0.000188	CcSEcCtD
Rizatriptan—Insomnia—Gabapentin—epilepsy syndrome	6.61e-05	0.000188	CcSEcCtD
Rizatriptan—Nausea—Lamotrigine—epilepsy syndrome	6.59e-05	0.000187	CcSEcCtD
Rizatriptan—Cough—Topiramate—epilepsy syndrome	6.57e-05	0.000187	CcSEcCtD
Rizatriptan—Feeling abnormal—Pregabalin—epilepsy syndrome	6.56e-05	0.000186	CcSEcCtD
Rizatriptan—Paraesthesia—Gabapentin—epilepsy syndrome	6.56e-05	0.000186	CcSEcCtD
Rizatriptan—Convulsion—Topiramate—epilepsy syndrome	6.52e-05	0.000185	CcSEcCtD
Rizatriptan—Gastrointestinal pain—Pregabalin—epilepsy syndrome	6.51e-05	0.000185	CcSEcCtD
Rizatriptan—Dyspnoea—Gabapentin—epilepsy syndrome	6.51e-05	0.000185	CcSEcCtD
Rizatriptan—Hypertension—Topiramate—epilepsy syndrome	6.5e-05	0.000185	CcSEcCtD
Rizatriptan—Somnolence—Gabapentin—epilepsy syndrome	6.49e-05	0.000184	CcSEcCtD
Rizatriptan—Hypersensitivity—Valproic Acid—epilepsy syndrome	6.49e-05	0.000184	CcSEcCtD
Rizatriptan—Dyspepsia—Gabapentin—epilepsy syndrome	6.43e-05	0.000183	CcSEcCtD
Rizatriptan—Chest pain—Topiramate—epilepsy syndrome	6.41e-05	0.000182	CcSEcCtD
Rizatriptan—Arthralgia—Topiramate—epilepsy syndrome	6.41e-05	0.000182	CcSEcCtD
Rizatriptan—Myalgia—Topiramate—epilepsy syndrome	6.41e-05	0.000182	CcSEcCtD
Rizatriptan—Anxiety—Topiramate—epilepsy syndrome	6.39e-05	0.000181	CcSEcCtD
Rizatriptan—Decreased appetite—Gabapentin—epilepsy syndrome	6.35e-05	0.00018	CcSEcCtD
Rizatriptan—Discomfort—Topiramate—epilepsy syndrome	6.33e-05	0.00018	CcSEcCtD
Rizatriptan—Urticaria—Pregabalin—epilepsy syndrome	6.33e-05	0.00018	CcSEcCtD
Rizatriptan—Asthenia—Valproic Acid—epilepsy syndrome	6.32e-05	0.00018	CcSEcCtD
Rizatriptan—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	6.31e-05	0.000179	CcSEcCtD
Rizatriptan—Fatigue—Gabapentin—epilepsy syndrome	6.3e-05	0.000179	CcSEcCtD
Rizatriptan—Abdominal pain—Pregabalin—epilepsy syndrome	6.3e-05	0.000179	CcSEcCtD
Rizatriptan—Body temperature increased—Pregabalin—epilepsy syndrome	6.3e-05	0.000179	CcSEcCtD
Rizatriptan—Dry mouth—Topiramate—epilepsy syndrome	6.27e-05	0.000178	CcSEcCtD
Rizatriptan—Constipation—Gabapentin—epilepsy syndrome	6.25e-05	0.000177	CcSEcCtD
Rizatriptan—Pain—Gabapentin—epilepsy syndrome	6.25e-05	0.000177	CcSEcCtD
Rizatriptan—Pruritus—Valproic Acid—epilepsy syndrome	6.23e-05	0.000177	CcSEcCtD
Rizatriptan—Confusional state—Topiramate—epilepsy syndrome	6.2e-05	0.000176	CcSEcCtD
Rizatriptan—Oedema—Topiramate—epilepsy syndrome	6.15e-05	0.000175	CcSEcCtD
Rizatriptan—Shock—Topiramate—epilepsy syndrome	6.05e-05	0.000172	CcSEcCtD
Rizatriptan—Diarrhoea—Valproic Acid—epilepsy syndrome	6.03e-05	0.000171	CcSEcCtD
Rizatriptan—Nervous system disorder—Topiramate—epilepsy syndrome	6.03e-05	0.000171	CcSEcCtD
Rizatriptan—Feeling abnormal—Gabapentin—epilepsy syndrome	6.02e-05	0.000171	CcSEcCtD
Rizatriptan—Tachycardia—Topiramate—epilepsy syndrome	6e-05	0.00017	CcSEcCtD
Rizatriptan—Gastrointestinal pain—Gabapentin—epilepsy syndrome	5.97e-05	0.00017	CcSEcCtD
Rizatriptan—Hyperhidrosis—Topiramate—epilepsy syndrome	5.94e-05	0.000169	CcSEcCtD
Rizatriptan—Hypersensitivity—Pregabalin—epilepsy syndrome	5.87e-05	0.000167	CcSEcCtD
Rizatriptan—Anorexia—Topiramate—epilepsy syndrome	5.86e-05	0.000166	CcSEcCtD
Rizatriptan—Dizziness—Valproic Acid—epilepsy syndrome	5.83e-05	0.000166	CcSEcCtD
Rizatriptan—Urticaria—Gabapentin—epilepsy syndrome	5.8e-05	0.000165	CcSEcCtD
Rizatriptan—Body temperature increased—Gabapentin—epilepsy syndrome	5.77e-05	0.000164	CcSEcCtD
Rizatriptan—Abdominal pain—Gabapentin—epilepsy syndrome	5.77e-05	0.000164	CcSEcCtD
Rizatriptan—Asthenia—Pregabalin—epilepsy syndrome	5.72e-05	0.000162	CcSEcCtD
Rizatriptan—Pruritus—Pregabalin—epilepsy syndrome	5.64e-05	0.00016	CcSEcCtD
Rizatriptan—Vomiting—Valproic Acid—epilepsy syndrome	5.6e-05	0.000159	CcSEcCtD
Rizatriptan—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	5.6e-05	0.000159	CcSEcCtD
Rizatriptan—Insomnia—Topiramate—epilepsy syndrome	5.56e-05	0.000158	CcSEcCtD
Rizatriptan—Rash—Valproic Acid—epilepsy syndrome	5.56e-05	0.000158	CcSEcCtD
Rizatriptan—Dermatitis—Valproic Acid—epilepsy syndrome	5.55e-05	0.000158	CcSEcCtD
Rizatriptan—Headache—Valproic Acid—epilepsy syndrome	5.52e-05	0.000157	CcSEcCtD
Rizatriptan—Paraesthesia—Topiramate—epilepsy syndrome	5.52e-05	0.000157	CcSEcCtD
Rizatriptan—Dyspnoea—Topiramate—epilepsy syndrome	5.48e-05	0.000156	CcSEcCtD
Rizatriptan—Somnolence—Topiramate—epilepsy syndrome	5.46e-05	0.000155	CcSEcCtD
Rizatriptan—Diarrhoea—Pregabalin—epilepsy syndrome	5.45e-05	0.000155	CcSEcCtD
Rizatriptan—Dyspepsia—Topiramate—epilepsy syndrome	5.41e-05	0.000154	CcSEcCtD
Rizatriptan—Hypersensitivity—Gabapentin—epilepsy syndrome	5.38e-05	0.000153	CcSEcCtD
Rizatriptan—Decreased appetite—Topiramate—epilepsy syndrome	5.34e-05	0.000152	CcSEcCtD
Rizatriptan—Gastrointestinal disorder—Topiramate—epilepsy syndrome	5.31e-05	0.000151	CcSEcCtD
Rizatriptan—Fatigue—Topiramate—epilepsy syndrome	5.3e-05	0.00015	CcSEcCtD
Rizatriptan—Dizziness—Pregabalin—epilepsy syndrome	5.27e-05	0.00015	CcSEcCtD
Rizatriptan—Pain—Topiramate—epilepsy syndrome	5.26e-05	0.000149	CcSEcCtD
Rizatriptan—Constipation—Topiramate—epilepsy syndrome	5.26e-05	0.000149	CcSEcCtD
Rizatriptan—Asthenia—Gabapentin—epilepsy syndrome	5.24e-05	0.000149	CcSEcCtD
Rizatriptan—Nausea—Valproic Acid—epilepsy syndrome	5.23e-05	0.000149	CcSEcCtD
Rizatriptan—Pruritus—Gabapentin—epilepsy syndrome	5.17e-05	0.000147	CcSEcCtD
Rizatriptan—Vomiting—Pregabalin—epilepsy syndrome	5.07e-05	0.000144	CcSEcCtD
Rizatriptan—Feeling abnormal—Topiramate—epilepsy syndrome	5.06e-05	0.000144	CcSEcCtD
Rizatriptan—Gastrointestinal pain—Topiramate—epilepsy syndrome	5.03e-05	0.000143	CcSEcCtD
Rizatriptan—Rash—Pregabalin—epilepsy syndrome	5.02e-05	0.000143	CcSEcCtD
Rizatriptan—Dermatitis—Pregabalin—epilepsy syndrome	5.02e-05	0.000143	CcSEcCtD
Rizatriptan—Diarrhoea—Gabapentin—epilepsy syndrome	5e-05	0.000142	CcSEcCtD
Rizatriptan—Headache—Pregabalin—epilepsy syndrome	4.99e-05	0.000142	CcSEcCtD
Rizatriptan—Urticaria—Topiramate—epilepsy syndrome	4.88e-05	0.000139	CcSEcCtD
Rizatriptan—Body temperature increased—Topiramate—epilepsy syndrome	4.86e-05	0.000138	CcSEcCtD
Rizatriptan—Abdominal pain—Topiramate—epilepsy syndrome	4.86e-05	0.000138	CcSEcCtD
Rizatriptan—Dizziness—Gabapentin—epilepsy syndrome	4.83e-05	0.000137	CcSEcCtD
Rizatriptan—Nausea—Pregabalin—epilepsy syndrome	4.73e-05	0.000134	CcSEcCtD
Rizatriptan—Vomiting—Gabapentin—epilepsy syndrome	4.64e-05	0.000132	CcSEcCtD
Rizatriptan—Rash—Gabapentin—epilepsy syndrome	4.61e-05	0.000131	CcSEcCtD
Rizatriptan—Dermatitis—Gabapentin—epilepsy syndrome	4.6e-05	0.000131	CcSEcCtD
Rizatriptan—Headache—Gabapentin—epilepsy syndrome	4.58e-05	0.00013	CcSEcCtD
Rizatriptan—Hypersensitivity—Topiramate—epilepsy syndrome	4.53e-05	0.000129	CcSEcCtD
Rizatriptan—Asthenia—Topiramate—epilepsy syndrome	4.41e-05	0.000125	CcSEcCtD
Rizatriptan—Pruritus—Topiramate—epilepsy syndrome	4.35e-05	0.000123	CcSEcCtD
Rizatriptan—Nausea—Gabapentin—epilepsy syndrome	4.34e-05	0.000123	CcSEcCtD
Rizatriptan—Diarrhoea—Topiramate—epilepsy syndrome	4.21e-05	0.000119	CcSEcCtD
Rizatriptan—Dizziness—Topiramate—epilepsy syndrome	4.06e-05	0.000115	CcSEcCtD
Rizatriptan—Vomiting—Topiramate—epilepsy syndrome	3.91e-05	0.000111	CcSEcCtD
Rizatriptan—Rash—Topiramate—epilepsy syndrome	3.88e-05	0.00011	CcSEcCtD
Rizatriptan—Dermatitis—Topiramate—epilepsy syndrome	3.87e-05	0.00011	CcSEcCtD
Rizatriptan—Headache—Topiramate—epilepsy syndrome	3.85e-05	0.000109	CcSEcCtD
Rizatriptan—Nausea—Topiramate—epilepsy syndrome	3.65e-05	0.000104	CcSEcCtD
Rizatriptan—HTR1A—Signaling by GPCR—CDC42—epilepsy syndrome	1.58e-05	9.23e-05	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—HTR2A—epilepsy syndrome	1.58e-05	9.21e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—GABBR1—epilepsy syndrome	1.58e-05	9.19e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—NTRK2—epilepsy syndrome	1.57e-05	9.14e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—SST—epilepsy syndrome	1.57e-05	9.14e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—CCR2—epilepsy syndrome	1.57e-05	9.14e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—ADRA2A—epilepsy syndrome	1.57e-05	9.14e-05	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—SLC2A1—epilepsy syndrome	1.56e-05	9.11e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—PLAT—epilepsy syndrome	1.56e-05	9.1e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—DUSP6—epilepsy syndrome	1.56e-05	9.06e-05	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—PLCB1—epilepsy syndrome	1.55e-05	9.01e-05	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—TH—epilepsy syndrome	1.54e-05	8.98e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—ADRA2A—epilepsy syndrome	1.54e-05	8.95e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—AVP—epilepsy syndrome	1.53e-05	8.94e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—PLAT—epilepsy syndrome	1.53e-05	8.91e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—HRH3—epilepsy syndrome	1.51e-05	8.81e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—CXCL12—epilepsy syndrome	1.51e-05	8.78e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—BDKRB2—epilepsy syndrome	1.51e-05	8.78e-05	CbGpPWpGaD
Rizatriptan—HTR1D—GPCR downstream signaling—POMC—epilepsy syndrome	1.51e-05	8.77e-05	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—TSC2—epilepsy syndrome	1.5e-05	8.75e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling by GPCR—PRKCB—epilepsy syndrome	1.5e-05	8.74e-05	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—AGT—epilepsy syndrome	1.5e-05	8.74e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling by GPCR—IL6ST—epilepsy syndrome	1.49e-05	8.7e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—UPB1—epilepsy syndrome	1.49e-05	8.7e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—ATIC—epilepsy syndrome	1.49e-05	8.7e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—NEU1—epilepsy syndrome	1.49e-05	8.7e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—OPRM1—epilepsy syndrome	1.49e-05	8.67e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—JUNB—epilepsy syndrome	1.48e-05	8.62e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—CNR1—epilepsy syndrome	1.48e-05	8.62e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—CXCL12—epilepsy syndrome	1.48e-05	8.6e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—BDKRB2—epilepsy syndrome	1.48e-05	8.6e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—PLCB1—epilepsy syndrome	1.47e-05	8.59e-05	CbGpPWpGaD
Rizatriptan—HTR1B—GPCR downstream signaling—POMC—epilepsy syndrome	1.47e-05	8.58e-05	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—APOE—epilepsy syndrome	1.47e-05	8.56e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling by GPCR—PRKCB—epilepsy syndrome	1.47e-05	8.56e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling by GPCR—IL6ST—epilepsy syndrome	1.46e-05	8.52e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—JUNB—epilepsy syndrome	1.45e-05	8.44e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—CNR1—epilepsy syndrome	1.45e-05	8.44e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—HTR7—epilepsy syndrome	1.44e-05	8.41e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—PLCB1—epilepsy syndrome	1.44e-05	8.41e-05	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—KDR—epilepsy syndrome	1.44e-05	8.39e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—HSD17B4—epilepsy syndrome	1.44e-05	8.38e-05	CbGpPWpGaD
Rizatriptan—HTR1A—GPCR downstream signaling—CCR5—epilepsy syndrome	1.44e-05	8.37e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—HTR7—epilepsy syndrome	1.41e-05	8.23e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—CCR3—epilepsy syndrome	1.41e-05	8.19e-05	CbGpPWpGaD
Rizatriptan—HTR1A—GPCR downstream signaling—HTR2A—epilepsy syndrome	1.41e-05	8.19e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—HBEGF—epilepsy syndrome	1.4e-05	8.16e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—PPP1R3C—epilepsy syndrome	1.39e-05	8.09e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—GBE1—epilepsy syndrome	1.39e-05	8.09e-05	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—PRKCB—epilepsy syndrome	1.39e-05	8.07e-05	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—IL6ST—epilepsy syndrome	1.38e-05	8.04e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—AKT3—epilepsy syndrome	1.38e-05	8.01e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—HBEGF—epilepsy syndrome	1.37e-05	7.99e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—NPY—epilepsy syndrome	1.37e-05	7.98e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—ATP2A2—epilepsy syndrome	1.37e-05	7.98e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling by GPCR—POMC—epilepsy syndrome	1.37e-05	7.96e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	1.36e-05	7.91e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—AKT3—epilepsy syndrome	1.35e-05	7.84e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—ADAM10—epilepsy syndrome	1.34e-05	7.83e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling by GPCR—POMC—epilepsy syndrome	1.34e-05	7.79e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling by GPCR—CCL2—epilepsy syndrome	1.34e-05	7.79e-05	CbGpPWpGaD
Rizatriptan—HTR1A—GPCR downstream signaling—AGT—epilepsy syndrome	1.33e-05	7.77e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—HSPB1—epilepsy syndrome	1.32e-05	7.7e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—CXCL2—epilepsy syndrome	1.32e-05	7.7e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—CRH—epilepsy syndrome	1.32e-05	7.7e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—CCL3—epilepsy syndrome	1.32e-05	7.7e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—OXT—epilepsy syndrome	1.32e-05	7.7e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—ADAM10—epilepsy syndrome	1.32e-05	7.66e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling by GPCR—CCL2—epilepsy syndrome	1.31e-05	7.63e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—ASAH1—epilepsy syndrome	1.31e-05	7.61e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—CCR5—epilepsy syndrome	1.3e-05	7.6e-05	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—HMOX1—epilepsy syndrome	1.29e-05	7.49e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—HTR2A—epilepsy syndrome	1.28e-05	7.44e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—STXBP1—epilepsy syndrome	1.27e-05	7.4e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—S100B—epilepsy syndrome	1.27e-05	7.4e-05	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—CAT—epilepsy syndrome	1.27e-05	7.39e-05	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—POMC—epilepsy syndrome	1.26e-05	7.35e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—SOCS3—epilepsy syndrome	1.26e-05	7.33e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—CDC42—epilepsy syndrome	1.26e-05	7.31e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—S100B—epilepsy syndrome	1.24e-05	7.25e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—ALAD—epilepsy syndrome	1.24e-05	7.21e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—NT5E—epilepsy syndrome	1.24e-05	7.21e-05	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—CCL2—epilepsy syndrome	1.24e-05	7.2e-05	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—ABCB1—epilepsy syndrome	1.23e-05	7.19e-05	CbGpPWpGaD
Rizatriptan—HTR1A—GPCR downstream signaling—PRKCB—epilepsy syndrome	1.23e-05	7.18e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—SOCS3—epilepsy syndrome	1.23e-05	7.17e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—TSC1—epilepsy syndrome	1.23e-05	7.16e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—PTK2B—epilepsy syndrome	1.23e-05	7.16e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—CDC42—epilepsy syndrome	1.23e-05	7.16e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—AVP—epilepsy syndrome	1.22e-05	7.08e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—AGT—epilepsy syndrome	1.21e-05	7.05e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—CCR2—epilepsy syndrome	1.2e-05	6.97e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—NTRK2—epilepsy syndrome	1.2e-05	6.97e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—SST—epilepsy syndrome	1.2e-05	6.97e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—AVP—epilepsy syndrome	1.19e-05	6.93e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—DUSP6—epilepsy syndrome	1.19e-05	6.9e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—ALDH7A1—epilepsy syndrome	1.18e-05	6.88e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—CACNA1A—epilepsy syndrome	1.18e-05	6.88e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—ADRA2A—epilepsy syndrome	1.17e-05	6.82e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—PLAT—epilepsy syndrome	1.17e-05	6.79e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—ST3GAL3—epilepsy syndrome	1.16e-05	6.73e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—HES1—epilepsy syndrome	1.15e-05	6.69e-05	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—GPX1—epilepsy syndrome	1.15e-05	6.69e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—ADSL—epilepsy syndrome	1.13e-05	6.6e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—HES1—epilepsy syndrome	1.13e-05	6.55e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—BDKRB2—epilepsy syndrome	1.12e-05	6.55e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—CXCL12—epilepsy syndrome	1.12e-05	6.55e-05	CbGpPWpGaD
Rizatriptan—HTR1A—GPCR downstream signaling—POMC—epilepsy syndrome	1.12e-05	6.54e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—PRKCB—epilepsy syndrome	1.12e-05	6.52e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—FYN—epilepsy syndrome	1.12e-05	6.51e-05	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—FGF2—epilepsy syndrome	1.12e-05	6.5e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—IL6ST—epilepsy syndrome	1.11e-05	6.49e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—H2AFX—epilepsy syndrome	1.11e-05	6.48e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—MEF2C—epilepsy syndrome	1.11e-05	6.47e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—GLUL—epilepsy syndrome	1.11e-05	6.47e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—JUNB—epilepsy syndrome	1.1e-05	6.43e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—CNR1—epilepsy syndrome	1.1e-05	6.43e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—PLCB1—epilepsy syndrome	1.1e-05	6.4e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—FYN—epilepsy syndrome	1.09e-05	6.37e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—CACNA1D—epilepsy syndrome	1.09e-05	6.35e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—H2AFX—epilepsy syndrome	1.09e-05	6.35e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—MEF2C—epilepsy syndrome	1.09e-05	6.34e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—HTR7—epilepsy syndrome	1.08e-05	6.27e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—YWHAZ—epilepsy syndrome	1.07e-05	6.26e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—NGF—epilepsy syndrome	1.06e-05	6.19e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—YWHAZ—epilepsy syndrome	1.05e-05	6.13e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—HBEGF—epilepsy syndrome	1.05e-05	6.09e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—NGF—epilepsy syndrome	1.04e-05	6.06e-05	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—RELA—epilepsy syndrome	1.04e-05	6.04e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—CCR5—epilepsy syndrome	1.03e-05	6.02e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—AKT3—epilepsy syndrome	1.03e-05	5.98e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—TXNRD1—epilepsy syndrome	1.02e-05	5.94e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—POMC—epilepsy syndrome	1.02e-05	5.94e-05	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—MTOR—epilepsy syndrome	1.02e-05	5.92e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—CCR5—epilepsy syndrome	1.01e-05	5.89e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—HTR2A—epilepsy syndrome	1.01e-05	5.89e-05	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—AGT—epilepsy syndrome	1.01e-05	5.86e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—ADAM10—epilepsy syndrome	1e-05	5.84e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—CCL2—epilepsy syndrome	9.98e-06	5.81e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—HTR2A—epilepsy syndrome	9.9e-06	5.77e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—AQP1—epilepsy syndrome	9.9e-06	5.77e-05	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—APOE—epilepsy syndrome	9.86e-06	5.74e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—TSC2—epilepsy syndrome	9.6e-06	5.59e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—AGT—epilepsy syndrome	9.59e-06	5.59e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	9.51e-06	5.54e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—S100B—epilepsy syndrome	9.48e-06	5.52e-05	CbGpPWpGaD
Rizatriptan—HTR1F—GPCR downstream signaling—AKT1—epilepsy syndrome	9.44e-06	5.5e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—TSC2—epilepsy syndrome	9.4e-06	5.48e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—APOE—epilepsy syndrome	9.4e-06	5.47e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—AGT—epilepsy syndrome	9.39e-06	5.47e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—SOCS3—epilepsy syndrome	9.38e-06	5.47e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—CDC42—epilepsy syndrome	9.36e-06	5.45e-05	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—CASP3—epilepsy syndrome	9.35e-06	5.44e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—KDR—epilepsy syndrome	9.21e-06	5.36e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—APOE—epilepsy syndrome	9.2e-06	5.36e-05	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—JUN—epilepsy syndrome	9.08e-06	5.29e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—AVP—epilepsy syndrome	9.06e-06	5.28e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—KDR—epilepsy syndrome	9.02e-06	5.25e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—CHRM3—epilepsy syndrome	8.95e-06	5.21e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—KCNJ11—epilepsy syndrome	8.95e-06	5.21e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—PRKCB—epilepsy syndrome	8.86e-06	5.16e-05	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—MMP9—epilepsy syndrome	8.83e-06	5.15e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—IL6ST—epilepsy syndrome	8.83e-06	5.14e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—PRKCB—epilepsy syndrome	8.68e-06	5.05e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—IL6ST—epilepsy syndrome	8.64e-06	5.03e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—HES1—epilepsy syndrome	8.57e-06	4.99e-05	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling by GPCR—AKT1—epilepsy syndrome	8.57e-06	4.99e-05	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—POMC—epilepsy syndrome	8.47e-06	4.94e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	8.34e-06	4.86e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—FYN—epilepsy syndrome	8.33e-06	4.85e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—H2AFX—epilepsy syndrome	8.3e-06	4.84e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—MEF2C—epilepsy syndrome	8.29e-06	4.83e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	8.17e-06	4.76e-05	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—SRC—epilepsy syndrome	8.15e-06	4.74e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—POMC—epilepsy syndrome	8.07e-06	4.7e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—YWHAZ—epilepsy syndrome	8.01e-06	4.67e-05	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—VEGFA—epilepsy syndrome	7.93e-06	4.62e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—NGF—epilepsy syndrome	7.92e-06	4.61e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—POMC—epilepsy syndrome	7.91e-06	4.6e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—CCL2—epilepsy syndrome	7.9e-06	4.6e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—CCL2—epilepsy syndrome	7.74e-06	4.51e-05	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—ALB—epilepsy syndrome	7.73e-06	4.5e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—CCR5—epilepsy syndrome	7.71e-06	4.49e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—HTR2A—epilepsy syndrome	7.54e-06	4.39e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—ABCG2—epilepsy syndrome	7.3e-06	4.25e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—TSC2—epilepsy syndrome	7.16e-06	4.17e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—AGT—epilepsy syndrome	7.16e-06	4.17e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—FGF2—epilepsy syndrome	7.14e-06	4.16e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—CYP2C19—epilepsy syndrome	7.11e-06	4.14e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—CYP11A1—epilepsy syndrome	7.07e-06	4.12e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	7.02e-06	4.09e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—APOE—epilepsy syndrome	7.01e-06	4.08e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—FGF2—epilepsy syndrome	6.99e-06	4.07e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—KDR—epilepsy syndrome	6.87e-06	4e-05	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—PTGS2—epilepsy syndrome	6.76e-06	3.94e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—RELA—epilepsy syndrome	6.63e-06	3.86e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—PRKCB—epilepsy syndrome	6.61e-06	3.85e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—IL6ST—epilepsy syndrome	6.59e-06	3.84e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—MTOR—epilepsy syndrome	6.5e-06	3.79e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—RELA—epilepsy syndrome	6.49e-06	3.78e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	6.4e-06	3.73e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—CYP2D6—epilepsy syndrome	6.38e-06	3.72e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—MTOR—epilepsy syndrome	6.36e-06	3.71e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—ADRA2A—epilepsy syndrome	6.07e-06	3.54e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—BCHE—epilepsy syndrome	6.05e-06	3.52e-05	CbGpPWpGaD
Rizatriptan—HTR1D—GPCR downstream signaling—AKT1—epilepsy syndrome	6.03e-06	3.51e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—POMC—epilepsy syndrome	6.02e-06	3.51e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—CASP3—epilepsy syndrome	5.98e-06	3.48e-05	CbGpPWpGaD
Rizatriptan—HTR1B—GPCR downstream signaling—AKT1—epilepsy syndrome	5.91e-06	3.44e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—CCL2—epilepsy syndrome	5.89e-06	3.43e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—CASP3—epilepsy syndrome	5.85e-06	3.41e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—JUN—epilepsy syndrome	5.81e-06	3.38e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—SLC2A1—epilepsy syndrome	5.77e-06	3.36e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—PLCB1—epilepsy syndrome	5.71e-06	3.32e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—JUN—epilepsy syndrome	5.69e-06	3.31e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—TH—epilepsy syndrome	5.69e-06	3.31e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—MMP9—epilepsy syndrome	5.65e-06	3.29e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	5.6e-06	3.26e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—MMP9—epilepsy syndrome	5.53e-06	3.22e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling by GPCR—AKT1—epilepsy syndrome	5.48e-06	3.19e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling by GPCR—AKT1—epilepsy syndrome	5.37e-06	3.12e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—FGF2—epilepsy syndrome	5.33e-06	3.1e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—SRC—epilepsy syndrome	5.21e-06	3.03e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—SRC—epilepsy syndrome	5.1e-06	2.97e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—VEGFA—epilepsy syndrome	5.07e-06	2.95e-05	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—AKT1—epilepsy syndrome	5.06e-06	2.95e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—VEGFA—epilepsy syndrome	4.97e-06	2.89e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—RELA—epilepsy syndrome	4.94e-06	2.88e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—MTOR—epilepsy syndrome	4.85e-06	2.82e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—HMOX1—epilepsy syndrome	4.75e-06	2.76e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—CAT—epilepsy syndrome	4.68e-06	2.73e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—ABCB1—epilepsy syndrome	4.55e-06	2.65e-05	CbGpPWpGaD
Rizatriptan—HTR1A—GPCR downstream signaling—AKT1—epilepsy syndrome	4.5e-06	2.62e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—CASP3—epilepsy syndrome	4.46e-06	2.6e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—JUN—epilepsy syndrome	4.33e-06	2.52e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—GPX1—epilepsy syndrome	4.23e-06	2.47e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—MMP9—epilepsy syndrome	4.21e-06	2.45e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—AKT1—epilepsy syndrome	4.09e-06	2.38e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—SRC—epilepsy syndrome	3.89e-06	2.26e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—VEGFA—epilepsy syndrome	3.78e-06	2.2e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—AGT—epilepsy syndrome	3.71e-06	2.16e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—APOE—epilepsy syndrome	3.64e-06	2.12e-05	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—AKT1—epilepsy syndrome	3.4e-06	1.98e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—AKT1—epilepsy syndrome	3.24e-06	1.89e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—AKT1—epilepsy syndrome	3.17e-06	1.85e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—POMC—epilepsy syndrome	3.13e-06	1.82e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—ALB—epilepsy syndrome	2.85e-06	1.66e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—PTGS2—epilepsy syndrome	2.49e-06	1.45e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—AKT1—epilepsy syndrome	2.41e-06	1.41e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—AKT1—epilepsy syndrome	1.25e-06	7.3e-06	CbGpPWpGaD
